NOUV | Nouveau Life Pharmaceuticals, Inc. Annual &

Annual Cash Flows

(In USD)

Breakdown	2022	2021	2020	2019	2007	2006
Operating Cash Flow	-	-	-	-	-22.9 Thousand	-84.94 Thousand
Net Income	-	-	-	-	-357.24 Thousand	-256.81 Thousand
Depreciation & Amortization	-	-	-	-	133.84 Thousand	53 Thousand
Deferred income taxes	-	-	-	-	-	-
Stock-based compensation	-	-	-	-	-	-
Change in working capital	-	-	-	-	91.58 Thousand	20.45 Thousand
Other non-cash items	-	-	-	-	108.91 Thousand	98.41 Thousand
Investing Cash Flow	-	-	-	-	-	-
Investments in PPE	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-
Investment purchases	-	-	-	-	-	-
Sales/Maturities of investments	-	-	-	-	-	-
Other Investing Activities	-	-	-	-	-	-
Financing Cash Flow	-	-	-	-	21.07 Thousand	83.35 Thousand
Debt repayment	-	-	-	-	-	-
Dividends payments	-	-	-	-	-	-
Common Stock Repurchased	-	-	-	-	-	-
Common Stock Issuance	-	-	-	-	20 Thousand	78.08 Thousand
Other Financing Activities	-	-	-	-	1070.00	5272.00
Accounts receivables	-	-	-	-	-	-
Accounts payables	-	-	-	-	-	-
Inventory	-	-	-	-	-	-
Other working capital	-	-	-	-	-	-
Cash at beginning of period	-	-	-	-	3533.00	946.00
Cash at end of period	-	-	-	-	3965.00	3533.00
Capital Expenditure	-	-	-	-	-	-
Effect of forex changes on cash	-	-	-	-	2269.00	4181.00
Net cash flow / Change in cash	-	-	-	-	432.00	2587.00
Free Cash Flow	-	-	-	-	-22.9 Thousand	-84.94 Thousand

Breakdown	2022 FY	2021 FY	2020 FY	2019 FY	2008 Q3	2008 Q2
Operating Cash Flow	-	-	-	-	-	-
Net Income	-	-	-	-	-125.56 Thousand	-112.24 Thousand
Depreciation & Amortization	-	-	-	-	80.82 Thousand	39.04 Thousand
Deferred income taxes	-	-	-	-	-	-
Stock-based compensation	-	-	-	-	-	-
Change in working capital	-	-	-	-	20.93 Thousand	45.83 Thousand
Other non-cash items	-	-	-	-	27.22 Thousand	27.22 Thousand
Investing Cash Flow	-	-	-	-	-	-
Investments in PPE	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-
Investment purchases	-	-	-	-	-	-
Sales/Maturities of investments	-	-	-	-	-	-
Other Investing Activities	-	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-1434.00	-1546.00
Debt repayment	-	-	-	-	-	-
Dividends payments	-	-	-	-	-	-
Common Stock Repurchased	-	-	-	-	-	-
Common Stock Issuance	-	-	-	-	-	-
Other Financing Activities	-	-	-	-	-1434.00	-1546.00
Accounts receivables	-	-	-	-	-	-
Accounts payables	-	-	-	-	-	-
Inventory	-	-	-	-	-	-
Other working capital	-	-	-	-	-	-
Cash at beginning of period	-	-	-	-	252.00	1521.00
Cash at end of period	-	-	-	-	347.00	252.00
Capital Expenditure	-	-	-	-	-	-
Effect of forex changes on cash	-	-	-	-	-1888.00	420.00
Net cash flow / Change in cash	-	-	-	-	95.00	-1269.00
Free Cash Flow	-	-	-	-	3417.00	-143.00